Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesCogent trial shows lack of adverse interaction between clopidogrel and stomach medicine
EurekAlert, 09/25/09
Results from a late breaking clinical trial called COGENT demonstrate that the combination of giving patients clopidogrel, a blood thinner commonly prescribed to patients with cardiovascular disease, and stomach medicines such as omeprazole, known as proton pump inhibitors, did not lead to adverse events, as some prior studies had suggested.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
How nutrition affects healthy aging
EurekAlert, 12/07/09
Polymer therapeutic protects gut from radiation damage, infection after cancer treatment
EurekAlert, 12/04/09
Cigarette smoking increases colorectal cancer risk
ScienceDaily, 12/04/09
Sponsor
Article Search
Sponsor